Mesenchymal Stem Cell-derived Pleiotropic Factor in the Treatment of Donor Sites

Clinical trial NCT04234750 · UNKNOWN

Trial details

NCT number: NCT04234750
Sponsor: Chinese PLA General Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Evaluate the Safety and Effectiveness of Mesenchymal Stem Cell Conditioned Medium-derived Pleiotropic Factor in Treating Donor Sites

Start date: 2019-10-17
Primary completion: 2020-12-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.